CME/CE

Jointly provided by Partners for Advancing Clinical Education (PACE) and DKBmed, LLC. 

Acknowledgement

This activity is supported by an independent educational grant from Gilead Sciences, Inc. 

Target Audience

The intended audience for this clinician webcast will be Physicians, Nurses and Nurse Practitioners and Physician Assistants. 

Educational Objectives

Upon completion of this activity, participants should be able to: 

  • Describe recent trends in HIV incidence. 
  • Discuss strategies to increase HIV testing and prevention. 
  • Assess strategies to improve care of women with HIV. 
  • Describe recommendations for infant feeding for women living with HIV. 

Disclosures

PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to PACE policies. Others involved in the planning of this activity have no relevant financial relationships. 

Faculty / Presenter Reported Financial Relationship

Faculty Conflicts of Interest
Justin Alves, RN, FNP-BC, ACRN, CARN, CNE None
Anna Maya Powell, MD, MS Royalties or Patent Beneficiary: UpToDate
Consultant, Advisor, Speaker: Cepheid, JunoBio

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and DKBmed LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Activity 1 (General HIV)

Physician Continuing Education

PACE designates this enduring material for a maximum of 0.25 AMA PRA Category 1.0 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.25 contact hours.

PA Continuing Medical Education

PACE has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1.0 CME credits. Approval is valid until May 4, 2026. PAs should only claim credit commensurate with the extent of their participation. 


Activity 2 (HIV and Women)

Physician Continuing Education

PACE designates this enduring material for a maximum of 0.5 AMA PRA Category 1.0 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.5 contact hours.

PA Continuing Medical Education

PACE has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1.0 CME credits. Approval is valid until May 4, 2026. PAs should only claim credit commensurate with the extent of their participation. 


Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

There are no fees for participating and receiving CME/CE credit for these activities. 

Request for Credit

If you wish to receive acknowledgment for completing these activities, please complete the evaluation. 

  • Release date: May 5, 2025 
  • Expiration date: May 4, 2026 

Estimated time to complete each activity: 30 minutes 

Hardware & Software Requirements

To access activities, users will need:  

  • A computer with an internet connection  
  • An HTML5 compliant web browser or Internet Explorer 8 (and higher)  

Contact Information

For additional information about the accreditation of this activity, please visit https://partnersed.com